Compound found in red wine opens door for new treatments for depression, anxiety
- Details
- Category: Research
Like to unwind with a glass of red wine after a stressful day? Don't give alcohol all the credit. New research has revealed that the plant compound resveratrol, which is found in red wine, displays anti-stress effects by blocking the expression of an enzyme related to the control of stress in the brain, according to a University at Buffalo-led study.
HIV vaccine nears clinical trial following new findings
- Details
- Category: Research
A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version. A pair of papers published July 17 in Science Translational Medicine describe how the vaccine - which uses a form of the common herpes virus cytomegalovirus, or CMV - was live-attenuated, or weakened so CMV couldn't spread as easily.
Review evaluates how AI could boost the success of clinical trials
- Details
- Category: Research
Big pharma and other drug developers are grappling with a dilemma: the era of blockbuster drugs is coming to an end. At the same time, adding new drugs to their portfolios is slow and expensive. It takes on average 10-15 years and $1.5-2B to get a new drug to market; approximately half of this time and investment is devoted to clinical trials.
Healthy lifestyle may offset genetic risk of dementia
- Details
- Category: Research
Living a healthy lifestyle may help offset a person's genetic risk of dementia, according to new research. The study was led by the University of Exeter - simultaneously published today in JAMA and presented at the Alzheimer's Association International Conference 2019 in Los Angeles.
More money, more gabapentin
- Details
- Category: Research
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine, and the increasing use of the drug suggests it may be being abused.
Natural antioxidant helps improve immune-based therapies by modulating T-cells
- Details
- Category: Research
Shikhar Mehrotra, Ph.D. and Xue-Zhong Yu, M.D., National Institutes of Health-funded researchers at the Medical University of South Carolina (MUSC), have discovered a way to improve immune-based treatments, such as adoptive T-cell therapy (ACT) and hematopoietic stem cell transplantation (HSCT), by modulating T-cells with thioredoxin, a powerful, naturally occurring antioxidant molecule.
Sports playbook helps doctors predict cancer patient outcomes
- Details
- Category: Research
In this season of global soccer competitions and hotly contested political primaries, bookies and pundits are scouring every evolving scrap of information and sifting through mountains of data in an effort to predict the outcome of the next game or election. These predictions can change on a dime, however, based on a player's poor pass or a candidate's stellar debate performance.
More Pharma News ...
- New study showing drug prolongs life for patients with ovarian cancer
- Artificial DNA can control release of active ingredients from drugs
- How gastric stem cells fight bacteria
- Pathogen engineered to self-destruct underlies cancer vaccine platform
- Human-on-a-chip model tests cancer drug efficacy and toxicity for therapeutic index
- Vitamin D may not help your heart
- Researchers identify enzyme that suppresses immune system in breast cancer